DAVITA INC. (DVA) FY2026 Q3 P&L / Income Statement

Published · Updated Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)

Key Takeaways

  • Other operating segments supplied 61% of the $157.90 M rise in revenue from a year earlier.
  • Counting internal sales, those segments grew 21% to $551.77 M; U.S. dialysis grew 2.4% to $3.05 B.
  • Sales U.S. dialysis made to DaVita's own other units rose to $22.01 M from $11.93 M.
  • U.S. dialysis still holds 87% of DaVita's $7.55 B of goodwill on September 30, 2026.

The Unvarnished Truth

Side businesses, 15% of DaVita's sales, delivered 61% of its growth

Strip out dialysis and DaVita's growth story looks very different. Its other operating segments, 15% of sales, supplied 61% of the $157.90 M rise in revenue from a year earlier. Counting sales to the rest of the group, they grew 21% to $551.77 M, while U.S. dialysis grew just 2.4%. Within those segments, revenue from sources other than patient care jumped to $163.01 M from $115.86 M. Yet the same segments posted an $18.64 M operating loss, dragged down by the $62.18 M write-down in China. Growth, in other words, arrived where the profits did not.

Why does dialysis sell inside its own group? U.S. dialysis booked $22.01 M of revenue from other DaVita segments this quarter, up from $11.93 M, and the group eliminates $24.12 M of such internal sales in total. The filing does not say which units were buying. What it does show is where the acquisition money sits: U.S. dialysis carries 87% of the $7.55 B of goodwill, while the other segments hold the China unit whose goodwill was just cut by $57.10 M. The segments that grow fastest are the ones carrying the write-down risk.

For investors, the filing describes a slow core and a fast, unprofitable fringe. The dialysis core grows slowly and pays the bills; the other segments grow fast but just lost money on paper. Management's own adjusted measure puts these segments' operating income at $44 million this quarter, down from $57 million in the quarter before. So even before the China charge, their profit shrank from the prior quarter. Watch whether integrated kidney care and the international clinics can turn their sales growth into steady profit. If the fastest-growing part of DaVita cannot earn money, what exactly is the growth worth?

Revenue by Business Segment (4 categories)

Swipe to see the full flow
DAVITA INC. (DVA) FY2026 Q3 P&L / Income StatementIncome statement for 2026-07-01 through 2026-09-30. View: Business segment (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUE RECONCILIATIONREVENUEOPERATINGPRE-TAXNETU S Dialysis And Related Lab Services with IntersegmentOther Operating Segments with IntersegmentTotal revenuesRevenue before reconciliation (calculated)U. S. Dialysis And Related Lab Services - Intersegment EliminationOther Operating Segment - Intersegment EliminationOperating incomeTotal operating expensesPatient care costsGeneral and administrativeDepreciation and amortizationEquity investment income, netGoodwill and other asset impairment chargesIncome before income taxesOther income (expense), net (calculated)Net incomeIncome tax expenseRevenue before reconciliation (calculated)Revenue beforereconciliation(calculated)$3.60 BTotal revenuesTotal revenues$3.58 BOperating incomeOperating income$499.26 MIncome before income taxesPretax income$358.71 MNet incomeNet income$269.39 MTotal operating expensesTotal operatingexpenses$3.08 BIncome tax expenseIncome tax expense$89.32 MU S Dialysis And Related Lab Services with IntersegmentU S Dialysis And Related LabServices with Intersegment$3.05 BOther income (expense), net (calculated)Other income,net (calculated)−$140.55 MPatient care costsPatient care costs$2.45 BOther Operating Segments with IntersegmentOther Operating Segmentswith Intersegment$551.77 MGeneral and administrativeGeneral and administrative$408.70 MDepreciation and amortizationDepreciation and amortization$165.19 MU. S. Dialysis And Related Lab Services - Intersegment EliminationIC Elim.: U. S.Dialysis And RelatedLab Services−$22.01 MEquity investment income, netEquity investment income, net−$8.24 MOther Operating Segment - Intersegment EliminationIC Elim.: OtherOperating Segment−$2.11 MGoodwill and other asset impairment chargesGoodwill and other assetimpairment charges$62.18 M
Chart details

DAVITA INC. (DVA) FY2026 Q3 P&L / Income Statement

Income statement for 2026-07-01 through 2026-09-30. View: Business segment (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues
3,578,126,000 US dollars
Total operating expenses
3,078,871,000 US dollars
Operating income
499,255,000 US dollars
Other income (expense), net (calculated)
negative 140,548,000 US dollars
Income before income taxes
358,707,000 US dollars
Income tax expense
89,318,000 US dollars
Net income
269,389,000 US dollars
U S Dialysis And Related Lab Services with Intersegment
3,050,478,000 US dollars
Other Operating Segments with Intersegment
551,766,000 US dollars
Patient care costs
2,451,047,000 US dollars
General and administrative
408,697,000 US dollars
Depreciation and amortization
165,188,000 US dollars
Equity investment income, net
negative 8,237,000 US dollars
Goodwill and other asset impairment charges
62,176,000 US dollars
Revenue before reconciliation (calculated)
3,602,244,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
U. S. Dialysis And Related Lab Services - Intersegment Elimination
negative 22,008,000 US dollars. Reported reconciliation to consolidated revenue.
Other Operating Segment - Intersegment Elimination
negative 2,110,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

  • Revenue minus operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
  • Of which attributable to DAVITA INC.: $222.93 M; to noncontrolling interests: $46.46 M.
DAVITA INC. (DVA) FY2026 Q3 Revenue by Business Segment (4 categories) Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Intelligent Insights for Investors

Which parts of DaVita's sales by business drove the change over the past year?

The other operating segments carried the growth, supplying 61% of the increase this quarter. Not everything rose: the deduction for U.S. dialysis sales made inside the group grew by $10.08 M.

Which part of DaVita's sales by business grew fastest over the past year?

The other operating segments: up 21% this quarter, against 4.6% for revenue as a whole.

How much does DaVita depend on the biggest piece of its sales by business?

Heavily: U.S. dialysis and related lab services brought in 85% of these sales this quarter, against 15% for the other operating segments.

Intelligent Insights for Lenders

Where is DaVita's acquisition goodwill concentrated across its divisions?

Mostly in U.S. dialysis: it carries 87% of the $7.55 B of goodwill from past acquisitions on DaVita's books on September 30, 2026.

Intelligent Insights for Employees

Which of DaVita's businesses brings in the most sales?

U.S. dialysis and related lab services carries the sales, with 85% this quarter. Next come the other operating segments, at 15%.

Intelligent Insights for Everyone

How has the mix of DaVita's sales by business shifted over the past year?

Toward the other operating segments: they made up 15% of revenue this quarter, against 13% a year earlier, while U.S. dialysis lost the most share.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!